深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

但去莫复问，白云无尽时。

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

草木有本心，何求美人折。

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

and at the same time I have no desire to go to extremities.' 'You'll not help your case by threatening me
🎉 🌹 🍀 🌻 🌈

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

for all day I have been imagining I detected the presence of cythyl.€o you imagine so now??I https://t.co/g8a9MhOFZy
🚩 🌹 💦 🌺 🎌 🌸 🎈 💎

[Hannah W. Song, Ph.D. @hannahwsong]

@AlkaDwivedi06 @ActImmuno @purwarrahul2 @hkJain_kmc @DrGauravNarula @NiraliShahMD @NCI_CCR_PedOnc Amazing achievement!

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

Hot off the press! A new article published in Cytotherapy from my group describing the differences in expansion platforms for CAR T-cells.
Check it out 👍
Congrats @hannahwsong !!

https://t.co/gXVWmPzPON

[CAR-TCR @CAR_TCell]

India's CAR-T cell therapy NexCAR19: How it fights and wins against cancer: https://t.co/VGDrhgkTeS #CARTCR

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

Here’s the link…

https://t.co/gI1l1tOUCH

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

Absolutely thrilled to share that this article is now online! Fantastic collaborative effort! Special thanks to Hannah, Mehdi, and Naomi for really knocking this out of the park! Enjoy the read!

[Javed Khan @JavedKhanOmics]

Our paper is out! "Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma" https://t.co/egrkNAKBz6

[CAR-TCR @CAR_TCell]

Rutgers Cancer Center treats 1st patient with its own manufactured T-cells: https://t.co/qeavcl6cyN #CARTCR #immunotherapy

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

Finally got a chance to this beautiful piece of architecture today! #ISCT2023

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

Special thanks to @DrPHanley for chairing our roundtable on managing factors affecting CT efficacy! #ISCT2023

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

Our super talented post bac - Roshini Traynor - had the chance to share her data today comparing CAR T-cells manufactured from whole blood vs apheresis! Great job!#nihpostbacposterday #nihclinicalcenter

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

Recently tested this pretty sweet instrument out as replacement for soon-to-be-retired Elutra. 🤩#invetechkorus #NIHdreamteam

[CAR-TCR @CAR_TCell]

CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma: https://t.co/LoWyIdgqui

#CARTCR #immunotherapy

[Rosandra Kaplan @rosiekaplanmd]

I mean it’s already an amazing effort I’m proud to be a part of to “drive” CARs and make CAR T therapy work better & the great name CARnation!!! Let’s go #ChildhoodCancerAwarenessMonth
@NiraliShahMD @cm35c @SRamakrishna_MD

[NIH @NIH]

News: First U.S. patient receives autologous stem cell therapy to treat dry AMD https://t.co/kY8daATAoF

[深圳/重庆天津成都广杭苏福徐州上海北京合肥青岛长沙厦门西安武汉东莞南京南昌济烟台珠海宁波赣州 @HighfillSteven]

Manuscript published today in the Journal of Translational Medicine from a very talented post-bac in my lab! She is looking for a good lab to call home for graduate school in 2022! Remley et al. @vickalicious42